These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8316228)

  • 21. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
    Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
    Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.
    Dean B; Sundram S; Bradbury R; Scarr E; Copolov D
    Neuroscience; 2001; 103(1):9-15. PubMed ID: 11311783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ca(2+)-dependent release from rat brain of cannabinoid receptor binding activity.
    Evans DM; Johnson MR; Howlett AC
    J Neurochem; 1992 Feb; 58(2):780-2. PubMed ID: 1729420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination and characterization of a cannabinoid receptor in rat brain.
    Devane WA; Dysarz FA; Johnson MR; Melvin LS; Howlett AC
    Mol Pharmacol; 1988 Nov; 34(5):605-13. PubMed ID: 2848184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid receptor localization in brain.
    Herkenham M; Lynn AB; Little MD; Johnson MR; Melvin LS; de Costa BR; Rice KC
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1932-6. PubMed ID: 2308954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups.
    Murphy BJ; Washkurak AW; Tuana BS
    Biochim Biophys Acta; 1990 May; 1052(2):333-9. PubMed ID: 2159349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
    Melvin LS; Milne GM; Johnson MR; Subramaniam B; Wilken GH; Howlett AC
    Mol Pharmacol; 1993 Nov; 44(5):1008-15. PubMed ID: 8246904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study.
    Massi P; Patrini G; Rubino T; Fuzio D; Parolaro D
    Pharmacol Biochem Behav; 1997 Sep; 58(1):73-8. PubMed ID: 9264073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
    Compton DR; Rice KC; De Costa BR; Razdan RK; Melvin LS; Johnson MR; Martin BR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):218-26. PubMed ID: 8474008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of sulfhydryl groups in cerebral cortical [3H]clonidine binding in developing rats.
    Kawai M; Nomura Y
    Eur J Pharmacol; 1983 Aug; 91(4):449-54. PubMed ID: 6311590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of a disulfide bond in the binding of flunitrazepam to the benzodiazepine receptor from bovine cerebral cortex.
    Otero de Bengtsson MS; Lacorazza HD; Biscoglio de Jiménez Bonino MJ; Medina JH
    J Neurochem; 1993 Feb; 60(2):536-42. PubMed ID: 8380435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles.
    Jansen EM; Haycock DA; Ward SJ; Seybold VS
    Brain Res; 1992 Mar; 575(1):93-102. PubMed ID: 1504787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins.
    Houston DB; Howlett AC
    Mol Pharmacol; 1993 Jan; 43(1):17-22. PubMed ID: 8423766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of thiol group(s) in the binding of 125I-labeled neurotensin to membranes from porcine brain.
    Mitra SP; Carraway RE
    Peptides; 1993; 14(2):185-9. PubMed ID: 8387186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
    Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
    Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study.
    Herkenham M; Lynn AB; Johnson MR; Melvin LS; de Costa BR; Rice KC
    J Neurosci; 1991 Feb; 11(2):563-83. PubMed ID: 1992016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization.
    Evans DM; Lake JT; Johnson MR; Howlett AC
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1271-7. PubMed ID: 8138940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfhydryl groups in receptor binding of thyrotropin-releasing hormone to rat amygdala.
    Sharif NA; Burt DR
    J Neurochem; 1984 Jan; 42(1):209-14. PubMed ID: 6315888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.
    Adams IB; Ryan W; Singer M; Thomas BF; Compton DR; Razdan RK; Martin BR
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1172-81. PubMed ID: 7791088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective effects of thiol reagents on the binding sites for imipramine and neurotransmitter amines in the rat brain.
    Biassoni R; Vaccari A
    Br J Pharmacol; 1985 Jun; 85(2):447-56. PubMed ID: 2992663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.